Sept. 2, 2025 —Corsera Health, Inc. has announced its launch with a mission to extend healthspan through cardiovascular ...
Sept. 2, 2025 — Johnson & Johnson MedTech has announced acute safety and effectiveness results from the Varipure ...
Sept. 2, 2025 — Stereotaxis has announced the successful completion of the world’s first procedures using MAGiC Sweep, a ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
Sept. 3, 2025 — Laza Medical, Inc., a developer of AI-powered robotic ultrasound image guidance technology, has ...
Patients with type 2 diabetes (T2D) and chronic kidney disease (CKD) are at elevated risk for cardiovascular disease.1 ...
Sept. 3, 2025 — Kardium Inc. recently announced it has received pre-market approval (PMA) for the Globe Pulsed Field ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Sept. 2, 2025 — Imperative Care, Inc. has announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its ...
Aug. 29, 2025 — GE HealthCare has launched Vivid Pioneer, its most advanced, ultra-premium and adaptive cardiovascular ...
Aug. 28, 2025 — A new global systematic literature review and meta-analysis has shown that herpes zoster vaccination ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Aug. 27, 2025 – HeartFocus, the AI-enabled cardiac imaging software developed by data-driven medtech company DESKi ...
Aug. 28, 2025 — Medtronic plc has announced it received U.S. Food and Drug Administration (FDA) approval for the ...
Aug. 26, 2025 — Octane, an innovative organization building the SoCal of Tomorrow by connecting people, resources and ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Aug. 28, 2025 — Leading up to the European Society of Cardiology (ESC) Congress 2025, GE HealthCare introduced its ...
Aug. 27, 2025 – The Cardiovascular Research Foundation (CRF) has announced the late-breaking clinical trials and science ...
Aug. 19, 2025 — Idorsia Ltd recently announced its novel dual endothelin receptor antagonist (ERA), Tryvio (aprocitentan ...
September 05, 2025
